SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-011647
Filing Date
2024-08-08
Accepted
2024-08-08 17:15:53
Documents
77
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q hook-20240630x10q.htm   iXBRL 10-Q 1703031
2 EX-1.1 hook-20240630xex1d1.htm EX-1.1 294170
3 EX-31.1 hook-20240630xex31d1.htm EX-31.1 9858
4 EX-31.2 hook-20240630xex31d2.htm EX-31.2 9866
5 EX-32.1 hook-20240630xex32d1.htm EX-32.1 8490
  Complete submission text file 0001558370-24-011647.txt   7700553

Data Files

Seq Description Document Type Size
6 EX-101.SCH hook-20240630.xsd EX-101.SCH 58315
7 EX-101.CAL hook-20240630_cal.xml EX-101.CAL 44926
8 EX-101.DEF hook-20240630_def.xml EX-101.DEF 240902
9 EX-101.LAB hook-20240630_lab.xml EX-101.LAB 474126
10 EX-101.PRE hook-20240630_pre.xml EX-101.PRE 360650
80 EXTRACTED XBRL INSTANCE DOCUMENT hook-20240630x10q_htm.xml XML 1155583
Mailing Address 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240 NEW YORK NY 10118 0114318906360
HOOKIPA Pharma Inc. (Filer) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38869 | Film No.: 241189642
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)